RIO DE JANEIRO, BRAZIL - It "has a broad antiviral spectrum that kills all viruses and all variants," words that sound too good to be true. They were said by the inventor of the nasal spray, biochemist Gilly Regev, an Israeli based in Canada, where she is one of the founders of SaNOtize Research and Development Corp.
Israel and New Zealand have given provisional approval for marketing the spray, which was tested in conjunction with two British scientific institutions.
The tests were phase two trials, with a smaller number of volunteers. The spray is multi-purpose: it works for prevention, to . . .